172 related articles for article (PubMed ID: 20877355)
21. Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
Park MH; Jo M; Won D; Song HS; Song MJ; Hong JT
Apoptosis; 2012 Dec; 17(12):1316-26. PubMed ID: 23007278
[TBL] [Abstract][Full Text] [Related]
22. Caudatin potentiates the anti-tumor effects of TRAIL against human breast cancer by upregulating DR5.
Fei HR; Yuan C; Wang GL; Zhao Y; Li ZJ; Du X; Wang FZ
Phytomedicine; 2019 Sep; 62():152950. PubMed ID: 31102888
[TBL] [Abstract][Full Text] [Related]
23. TRAIL-activated stress kinases suppress apoptosis through transcriptional upregulation of MCL-1.
Son JK; Varadarajan S; Bratton SB
Cell Death Differ; 2010 Aug; 17(8):1288-301. PubMed ID: 20168333
[TBL] [Abstract][Full Text] [Related]
24. Gamma-tocotrienol promotes TRAIL-induced apoptosis through reactive oxygen species/extracellular signal-regulated kinase/p53-mediated upregulation of death receptors.
Kannappan R; Ravindran J; Prasad S; Sung B; Yadav VR; Reuter S; Chaturvedi MM; Aggarwal BB
Mol Cancer Ther; 2010 Aug; 9(8):2196-207. PubMed ID: 20682650
[TBL] [Abstract][Full Text] [Related]
25. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
[TBL] [Abstract][Full Text] [Related]
26. A functional, new short isoform of death receptor 4 in Ewing's sarcoma cell lines may be involved in TRAIL sensitivity/resistance mechanisms.
Picarda G; Surget S; Guiho R; Téletchéa S; Berreur M; Tirode F; Pellat-Deceunynck C; Heymann D; Trichet V; Rédini F
Mol Cancer Res; 2012 Mar; 10(3):336-46. PubMed ID: 22258765
[TBL] [Abstract][Full Text] [Related]
27. Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.
Raguénez G; Mühlethaler-Mottet A; Meier R; Duros C; Bénard J; Gross N
BMC Cancer; 2009 Mar; 9():97. PubMed ID: 19331667
[TBL] [Abstract][Full Text] [Related]
28. Kaempferol Sensitizes Human Ovarian Cancer Cells-OVCAR-3 and SKOV-3 to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis via JNK/ERK-CHOP Pathway and Up-Regulation of Death Receptors 4 and 5.
Zhao Y; Tian B; Wang Y; Ding H
Med Sci Monit; 2017 Oct; 23():5096-5105. PubMed ID: 29070784
[TBL] [Abstract][Full Text] [Related]
29. Proteasome inhibitor Bortezomib induces cell cycle arrest and apoptosis in cell lines derived from Ewing's sarcoma family of tumors and synergizes with TRAIL.
Lu G; Punj V; Chaudhary PM
Cancer Biol Ther; 2008 Apr; 7(4):603-8. PubMed ID: 18223318
[TBL] [Abstract][Full Text] [Related]
30. Gefitinib enhances human colon cancer cells to TRAIL-induced apoptosis of via autophagy- and JNK-mediated death receptors upregulation.
Chen L; Meng Y; Guo X; Sheng X; Tai G; Zhang F; Cheng H; Zhou Y
Apoptosis; 2016 Nov; 21(11):1291-1301. PubMed ID: 27629794
[TBL] [Abstract][Full Text] [Related]
31. Basic fibroblast growth factor (bFGF)-induced cell death is mediated through a caspase-dependent and p53-independent cell death receptor pathway.
Westwood G; Dibling BC; Cuthbert-Heavens D; Burchill SA
Oncogene; 2002 Jan; 21(5):809-24. PubMed ID: 11850809
[TBL] [Abstract][Full Text] [Related]
32. Bakuchiol sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
Park MH; Kim JH; Chung YH; Lee SH
Biochem Biophys Res Commun; 2016 Apr; 473(2):586-92. PubMed ID: 27033605
[TBL] [Abstract][Full Text] [Related]
33. Fas-mediated apoptosis in Ewing's sarcoma cell lines by metalloproteinase inhibitors.
Mitsiades N; Poulaki V; Leone A; Tsokos M
J Natl Cancer Inst; 1999 Oct; 91(19):1678-84. PubMed ID: 10511596
[TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase inhibitor-mediated sensitization to TRAIL-induced apoptosis in childhood malignancies is not associated with upregulation of TRAIL receptor expression, but with potentiated caspase-8 activation.
Sonnemann J; Trommer N; Becker S; Wittig S; Grauel D; Palani CD; Beck JF
Cancer Biol Ther; 2012 Apr; 13(6):417-24. PubMed ID: 22313685
[TBL] [Abstract][Full Text] [Related]
35. A novel synthetic analogue of ω-3 17,18-epoxyeicosatetraenoic acid activates TNF receptor-1/ASK1/JNK signaling to promote apoptosis in human breast cancer cells.
Dyari HRE; Rawling T; Chen Y; Sudarmana W; Bourget K; Dwyer JM; Allison SE; Murray M
FASEB J; 2017 Dec; 31(12):5246-5257. PubMed ID: 28798154
[TBL] [Abstract][Full Text] [Related]
36. Manipulation of oxidative stress to induce cell death in Ewing's sarcoma family of tumours.
Magwere T; Myatt SS; Burchill SA
Eur J Cancer; 2008 Oct; 44(15):2276-87. PubMed ID: 18656345
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial division inhibitor 1 (mdivi-1) enhances death receptor-mediated apoptosis in human ovarian cancer cells.
Wang J; Hansen K; Edwards R; Van Houten B; Qian W
Biochem Biophys Res Commun; 2015 Jan; 456(1):7-12. PubMed ID: 25446129
[TBL] [Abstract][Full Text] [Related]
38. Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.
Woo JS; Kim SM; Jeong CH; Ryu CH; Jeun SS
Biochem Biophys Res Commun; 2013 Feb; 431(2):354-9. PubMed ID: 23261452
[TBL] [Abstract][Full Text] [Related]
39. Ilimaquinone induces death receptor expression and sensitizes human colon cancer cells to TRAIL-induced apoptosis through activation of ROS-ERK/p38 MAPK-CHOP signaling pathways.
Do MT; Na M; Kim HG; Khanal T; Choi JH; Jin SW; Oh SH; Hwang IH; Chung YC; Kim HS; Jeong TC; Jeong HG
Food Chem Toxicol; 2014 Sep; 71():51-9. PubMed ID: 24930757
[TBL] [Abstract][Full Text] [Related]
40. PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells.
Maginn EN; Browne PV; Hayden P; Vandenberghe E; MacDonagh B; Evans P; Goodyer M; Tewari P; Campiani G; Butini S; Williams DC; Zisterer DM; Lawler MP; McElligott AM
Br J Cancer; 2011 Jan; 104(2):281-9. PubMed ID: 21179037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
